As of 2026-09-20, the Intrinsic Value of Sotera Health Co (SHC) is 14.61 USD. This SHC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 18.73 USD, the upside of Sotera Health Co is -22.00%.
The range of the Intrinsic Value is 8.75 - 29.09 USD
Based on its market price of 18.73 USD and our intrinsic valuation, Sotera Health Co (SHC) is overvalued by 22.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 8.75 - 29.09 | 14.61 | -22.0% |
| DCF (Growth 10y) | 12.07 - 34.43 | 18.56 | -0.9% |
| DCF (EBITDA 5y) | 26.19 - 47.49 | 37.81 | 101.9% |
| DCF (EBITDA 10y) | 28.03 - 52.61 | 40.75 | 117.6% |
| Fair Value | 10.33 - 10.33 | 10.33 | -44.86% |
| P/E | 10.29 - 18.71 | 15.09 | -19.4% |
| EV/EBITDA | 27.16 - 63.19 | 43.20 | 130.6% |
| EPV | (0.18) - 1.49 | 0.66 | -96.5% |
| DDM - Stable | 3.18 - 8.96 | 6.07 | -67.6% |
| DDM - Multi | 4.09 - 9.16 | 5.68 | -69.7% |
| Market Cap (mil) | 5,341.23 |
| Beta | 1.45 |
| Outstanding shares (mil) | 285.17 |
| Enterprise Value (mil) | 7,262.17 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.62% |
| Cost of Debt | 6.98% |
| WACC | 8.65% |